Close
Novotech
Jabsco PureFlo 21 Single Use

Genome Valley emerges as Indias Top Life Sciences Cluster

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...
- Advertisement -

World Pharma Today / News / India – Genome Valley, Hyderabad by shipping one-third of the world’s vaccine demand among children has beaten Chennai and Bengaluru to become India’s top life sciences cluster. It is considered by many as Asia’s answer to the Boston Life Sciences Corridor, the US cluster which happens to be largest globally. Driving this massive supply of vaccines here are Pharma majors such as Bharat Biotech, Shantha Biotechnics, Indian Immunologicals Limited, and Biological E and many more. Vaccines supplied from here include Tetanus-Diphtheria (combination), Pentavalent, Japanese Encephalitis, Rotavirus, Typhoid Conjugate, and Hepatitis B&C.

This cluster is located at around 60 kms. from the city and houses 200 major firms that have more than 10000 employees working. India contributes 70% of the world’s vaccine market. There has been a significant amount of investment which Genome Valley has been able to draw in the last three years. The investment hovers between 6000-6500 crores which is massive. Besides, there are many top-end brands from Switzerland, Canada, and India that are making their way into the cluster.

Latest stories

Related stories

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...

Biomaterials and Local Drug Delivery in Implant Surgery

Advances in biomaterials and localized drug delivery systems are...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »